复方丹参注射液联合血液透析对终末期肾病合并心力衰竭患者的疗效及氧化指标的影响

来源 :中医药导报 | 被引量 : 0次 | 上传用户:t573249005
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨复方丹参注射液联合血液透析对终末期肾病合并心力衰竭患者临床疗效和氧化应激指标的影响。方法:选取终末期肾病合并心衰患者72例,随机均分为对照组和治疗组,对照组进行常规治疗,治疗组在对照组基础上使用复方丹参注射液进行治疗,观察两组患者的总体疗效、心功能、左心室形态、活动能力、氧化指标及药物安全性。结果:治疗后治疗组显效率(38.9%)和总有效率(83.3%)均明显高于对照组,差异有统计学意义(P<0.05);与对照组比较,治疗组左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、室间隔厚度(IVST)、左室后壁厚度(LVPWT)均显著减小,左室射血分数(LVEF)及6 min步行距离均显著增加,差异均有统计学意义(P<0.05);与对照组比较,治疗组血浆中丙二醛(MDA)含量明显下降,超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)活性明显上调,差异均有统计学意义(P<0.05);两组药物治疗安全性比较,差异无统计学意义(P>0.05)。结论:复方丹参注射液联合血液透析治疗终末期肾病合并心力衰竭效果显著,可改善患者心功能,减轻氧化应激损伤。 Objective: To investigate the effect of compound Danshen injection combined with hemodialysis on clinical efficacy and oxidative stress in patients with end-stage renal disease complicated with heart failure. Methods: Seventy-two patients with end-stage renal disease complicated with heart failure were randomly divided into control group and treatment group. The control group was treated routinely. The treatment group was treated with compound Danshen injection on the basis of the control group. Efficacy, cardiac function, left ventricular morphology, activity, oxidation and drug safety. Results: After treatment, the effective rate (38.9%) and total effective rate (83.3%) of the treatment group were significantly higher than that of the control group, the difference was statistically significant (P <0.05); compared with the control group, (LVESD), LVEDD, IVST and LVPWT were significantly decreased, left ventricular ejection fraction (LVEF) and walking distance at 6 min were significantly increased, (P <0.05). Compared with the control group, the content of malondialdehyde (MDA) in the plasma of the treatment group decreased significantly. The contents of superoxide dismutase (SOD), catalase (CAT) The activity of GSH-Px was significantly up-regulated with statistical significance (P <0.05). There was no significant difference in the safety of drug treatment between the two groups (P> 0.05). Conclusion: The compound Danshen injection combined with hemodialysis treatment of end-stage renal disease with heart failure effect is significant, can improve cardiac function and reduce oxidative stress injury.
其他文献
目的:探讨牡蛎提取物对足细胞裂孔膜蛋白NEPHRIN细胞外调节蛋白激酶(ERK)通路的影响。方法:体内实验采用一次性尾静脉注射阿霉素(adriamycin,ADR)的方法,建立阿霉素肾病大鼠
期刊
@@
目的:观察五七散治疗非甾体类抗炎药相关性胃溃疡的疗效。方法:将60例非甾体类抗炎药相关性胃溃疡患者随机分为治疗组和对照组,每组30例。治疗组服用五七散,对照组口服雷贝拉
Long, long ago, somewhere among the mountains of Japan, there lived a poor woodcutter and his wife. They were very old and had no children. Every day the husban
目的:观察以行气化痰法治疗非酒精性脂肪性肝炎的临床疗效.方法:选择门诊非酒精性脂肪性肝炎(痰瘀互结证)患者70例,将其随机分为治疗组35例和对照组35例,治疗组以行气化痰调
期刊
@@
目的:观察温阳利水法联合西药治疗心肾阳虚型慢性心力衰竭的临床效果.方法:将我院收治的62例心肾阳虚型慢性心力衰竭患者随机分为治疗组和对照组.两组均接受常规西药治疗,治
期刊
@@
目的:观察参芪降糖颗粒对糖尿病患者脑功能减退的影响及临床疗效。方法:将98例糖尿病合并脑功能减退患者随机分为治疗组(n=49)和对照组(n=49),对照组给予常规糖尿病+营养神经
目的:观察心康冲剂对慢性心衰大鼠AVP m RNA表达的影响。方法:70只SD大鼠随机抽取10只为正常对照组,剩余大鼠腹腔注射盐酸多柔比星建立CHF模型,再随机分为模型对照组、心康冲
连建伟教授认为慢性萎缩性胃炎的病因病机是脾胃虚弱为本,气滞湿热瘀血热毒为标,导致胃气失和,络脉瘀阻,胃失濡养而萎缩;其根据“治中焦如衡,非平不安”的治则以及萎缩性胃炎
期刊
@@
To study the variations in surface hydrography and circulation in northern South China Sea (NSCS), rotated empirical orthogonal function (REOF) and extended ass
目的:观察化腐生肌膏辅助脱落细胞真皮移植治疗难愈性烧伤创面的临床疗效。方法:将烧伤难愈性创面患者78例随机分为两组,每组39例,均予两组患者行常规清创,对照组在常规治疗